GLS and alcoholic liver diseases: Our study reveals a previously unrecognized regulatory mechanism in which glutaminase 1 (GLS1) modulates RNA polymerase II activity, providing a molecular foundation for understanding the hepatoprotective effects of a high‐protein diet in alcoholic liver disease (AFLD) (Figure8).